Gemfibrozil

CAS 25812-30-0 8 current records 12 historicalSmall Molecule

Who holds supplier records for Gemfibrozil? 8 organisations hold a current record for Gemfibrozil: an active US FDA Type II Drug Master File or a CEP. A further 12 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), Netherlands (1), China (1), France (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Gemfibrozil: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/gemfibrozil

Reading the evidence

  • 8 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (8)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Gemfibrozil. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Gemfibrozil sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (4)

Certificates of Suitability on the EDQM register for Gemfibrozil, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 5 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HIKAL LIMITED BengaluruIN
CEP 2007-089 - Rev 06
Gemfibrozil
Feb 2026Inspected Nov 2025
Switzerland
ZHEJIANG EXCEL PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2008-118 - Rev 02
Gemfibrozil
Feb 2026—
TAPI NL B.V. AmsterdamNL
CEP 2006-210 - Rev 06
Gemfibrozil
Jul 2025—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2006-221 - Rev 05
Gemfibrozil
Dec 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (12)

Organisations whose Type II DMFs for Gemfibrozil are no longer active. These show a past filing, not current supply.

Show all 12 historical records
  • SIGNA SA DE CV
    Inactive DMF 15412, 26146 · filed Apr 2011
  • SHANDONG WEIFANG PHARMACEUTICAL FACTORY CO LTD
    Inactive DMF 20323 · filed Mar 2007
  • India · Inactive DMF 18464 · filed Jun 2005
  • SHANGHAI SUNVE PHARMACEUTICAL CO LTD
    Inactive DMF 18132 · filed Mar 2005
  • China · Inactive DMF 18124 · filed Feb 2005
  • GANES CHEMICALS INC PENNSVILLE DIV
    Inactive DMF 9880 · filed Sept 1992
  • Italy · Inactive DMF 9796 · filed Jul 1992
  • SIEGFRIED AG
    Inactive DMF 9071 · filed Apr 1991
  • FRANCIS SPA
    Inactive DMF 7764 · filed Nov 1988
  • DINAMITE DIPHARMA SPA
    Inactive DMF 7430 · filed Apr 1988
  • BLASCHIM SPA
    Inactive DMF 7212 · filed Oct 1987
  • SIBEFAT SPA
    Inactive DMF 6874 · filed Mar 1987

Overview

Gemfibrozil is an antihyperlipidemic agent that reduces cholesterol and triglyceride levels in the blood with a particular effect on reducing triglycerides and raising HDL cholesterol. It is primarily used to treat dyslipidemia and prevent cardiovascular disease.

Chemical identity

IUPAC name
5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid
Canonical SMILES
CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
InChIKey
HEMJJKBWTPKOJG-UHFFFAOYSA-N
Synonyms
Lopid API, ci-719, lopid, nsc-757024

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Peroxisome Proliferator Receptor alpha Agonist
Mechanism of action
Peroxisome Proliferator-activated Receptor alpha Agonists
Chemical structure
Fibric Acids; PPAR alpha

Therapeutic areas

CardiovascularMetabolic

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Gemfibrozil?

8 organisations hold an active US FDA Type II Drug Master File or a CEP for Gemfibrozil: APITORIA PHARMA PRIVATE LTD (India), HIKAL LTD (India), TAPI NL BV (Netherlands), Zhejiang Excel Pharmaceutical Company., Ltd. (China), Cadila Pharmaceuticals Limited (India), ISOCHEM SA (France), Piramal Pharma Limited (India) and SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Gemfibrozil Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 19454), HIKAL LTD (DMF 18815), TAPI NL BV (DMF 7445), Zhejiang Excel Pharmaceutical Company., Ltd. (DMF 19407), Cadila Pharmaceuticals Limited (DMF 34933), ISOCHEM SA (DMF 18056), Piramal Pharma Limited (DMF 20437) and SOCIETA ITALIANA MEDICINALI SCANDICCI SIMS SRL (DMF 9058). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Gemfibrozil records mean?

12 organisations have only inactive Type II DMFs for Gemfibrozil. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Gemfibrozil have a European Certificate of Suitability?

Yes. 4 organisations hold a valid CEP for Gemfibrozil on the EDQM register, including HIKAL LIMITED Bengaluru (IN), ZHEJIANG EXCEL PHARMACEUTICAL CO., LTD. Taizhou (CN), TAPI NL B.V. Amsterdam (NL) and APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Gemfibrozil supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Gemfibrozil?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.